1 Market Overview

• 1.1 Product Overview and Scope
• 1.2 Market Estimation Caveats and Base Year
• 1.3 Market Analysis by Type
  • 1.3.1 Overview: Global IMP4279 Consumption Value by Type: 2021 Versus 2025 Versus 2032
  • 1.3.2 10mg
  • 1.3.3 50mg
• 1.4 Market Analysis by Dosage Form
  • 1.4.1 Overview: Global IMP4279 Consumption Value by Dosage Form: 2021 Versus 2025 Versus 2032
  • 1.4.2 Freeze-Dried Powder for Injection
  • 1.4.3 Capsule
• 1.5 Market Analysis by Route of Administration
  • 1.5.1 Overview: Global IMP4279 Consumption Value by Route of Administration: 2021 Versus 2025 Versus 2032
  • 1.5.2 Oral Administration
  • 1.5.3 Intravenous Injection
• 1.6 Market Analysis by Sales Channels
  • 1.6.1 Overview: Global IMP4279 Consumption Value by Sales Channels: 2021 Versus 2025 Versus 2032
  • 1.6.2 Hospital
  • 1.6.3 Retail
  • 1.6.4 Online
• 1.7 Market Analysis by Application
  • 1.7.1 Overview: Global IMP4279 Consumption Value by Application: 2021 Versus 2025 Versus 2032
  • 1.7.2 Peripheral T-Cell Lymphoma (PTCL)
  • 1.7.3 Relapsed Or Refractory Peripheral T-Cell Lymphoma (R/R PTCL)
  • 1.7.4 T-Cell Hematologic Malignancies
  • 1.7.5 Others
• 1.8 Global IMP4279 Market Size & Forecast
  • 1.8.1 Global IMP4279 Consumption Value (2021 & 2025 & 2032)
  • 1.8.2 Global IMP4279 Sales Quantity (2021-2032)
  • 1.8.3 Global IMP4279 Average Price (2021-2032)

2 Manufacturers Profiles

• 2.1 Nanjing IMPACT Therapeutics
  • 2.1.1 Nanjing IMPACT Therapeutics Details
  • 2.1.2 Nanjing IMPACT Therapeutics Major Business
  • 2.1.3 Nanjing IMPACT Therapeutics IMP4279 Product and Services
  • 2.1.4 Nanjing IMPACT Therapeutics IMP4279 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  • 2.1.5 Nanjing IMPACT Therapeutics Recent Developments/Updates

3 Competitive Environment: IMP4279 by Manufacturer

• 3.1 Global IMP4279 Sales Quantity by Manufacturer (2021-2026)
• 3.2 Global IMP4279 Revenue by Manufacturer (2021-2026)
• 3.3 Global IMP4279 Average Price by Manufacturer (2021-2026)
• 3.4 Market Share Analysis (2025)
  • 3.4.1 Producer Shipments of IMP4279 by Manufacturer Revenue ($MM) and Market Share (%): 2025
  • 3.4.2 Top 3 IMP4279 Manufacturer Market Share in 2025
  • 3.4.3 Top 6 IMP4279 Manufacturer Market Share in 2025
• 3.5 IMP4279 Market: Overall Company Footprint Analysis
  • 3.5.1 IMP4279 Market: Region Footprint
  • 3.5.2 IMP4279 Market: Company Product Type Footprint
  • 3.5.3 IMP4279 Market: Company Product Application Footprint
• 3.6 New Market Entrants and Barriers to Market Entry
• 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

• 4.1 Global IMP4279 Market Size by Region
  • 4.1.1 Global IMP4279 Sales Quantity by Region (2021-2032)
  • 4.1.2 Global IMP4279 Consumption Value by Region (2021-2032)
  • 4.1.3 Global IMP4279 Average Price by Region (2021-2032)
• 4.2 North America IMP4279 Consumption Value (2021-2032)
• 4.3 Europe IMP4279 Consumption Value (2021-2032)
• 4.4 Asia-Pacific IMP4279 Consumption Value (2021-2032)
• 4.5 South America IMP4279 Consumption Value (2021-2032)
• 4.6 Middle East & Africa IMP4279 Consumption Value (2021-2032)

5 Market Segment by Type

• 5.1 Global IMP4279 Sales Quantity by Type (2021-2032)
• 5.2 Global IMP4279 Consumption Value by Type (2021-2032)
• 5.3 Global IMP4279 Average Price by Type (2021-2032)

6 Market Segment by Application

• 6.1 Global IMP4279 Sales Quantity by Application (2021-2032)
• 6.2 Global IMP4279 Consumption Value by Application (2021-2032)
• 6.3 Global IMP4279 Average Price by Application (2021-2032)

7 North America

• 7.1 North America IMP4279 Sales Quantity by Type (2021-2032)
• 7.2 North America IMP4279 Sales Quantity by Application (2021-2032)
• 7.3 North America IMP4279 Market Size by Country
  • 7.3.1 North America IMP4279 Sales Quantity by Country (2021-2032)
  • 7.3.2 North America IMP4279 Consumption Value by Country (2021-2032)
  • 7.3.3 United States Market Size and Forecast (2021-2032)
  • 7.3.4 Canada Market Size and Forecast (2021-2032)
  • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

• 8.1 Europe IMP4279 Sales Quantity by Type (2021-2032)
• 8.2 Europe IMP4279 Sales Quantity by Application (2021-2032)
• 8.3 Europe IMP4279 Market Size by Country
  • 8.3.1 Europe IMP4279 Sales Quantity by Country (2021-2032)
  • 8.3.2 Europe IMP4279 Consumption Value by Country (2021-2032)
  • 8.3.3 Germany Market Size and Forecast (2021-2032)
  • 8.3.4 France Market Size and Forecast (2021-2032)
  • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
  • 8.3.6 Russia Market Size and Forecast (2021-2032)
  • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

• 9.1 Asia-Pacific IMP4279 Sales Quantity by Type (2021-2032)
• 9.2 Asia-Pacific IMP4279 Sales Quantity by Application (2021-2032)
• 9.3 Asia-Pacific IMP4279 Market Size by Region
  • 9.3.1 Asia-Pacific IMP4279 Sales Quantity by Region (2021-2032)
  • 9.3.2 Asia-Pacific IMP4279 Consumption Value by Region (2021-2032)
  • 9.3.3 China Market Size and Forecast (2021-2032)
  • 9.3.4 Japan Market Size and Forecast (2021-2032)
  • 9.3.5 South Korea Market Size and Forecast (2021-2032)
  • 9.3.6 India Market Size and Forecast (2021-2032)
  • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
  • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

• 10.1 South America IMP4279 Sales Quantity by Type (2021-2032)
• 10.2 South America IMP4279 Sales Quantity by Application (2021-2032)
• 10.3 South America IMP4279 Market Size by Country
  • 10.3.1 South America IMP4279 Sales Quantity by Country (2021-2032)
  • 10.3.2 South America IMP4279 Consumption Value by Country (2021-2032)
  • 10.3.3 Brazil Market Size and Forecast (2021-2032)
  • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

• 11.1 Middle East & Africa IMP4279 Sales Quantity by Type (2021-2032)
• 11.2 Middle East & Africa IMP4279 Sales Quantity by Application (2021-2032)
• 11.3 Middle East & Africa IMP4279 Market Size by Country
  • 11.3.1 Middle East & Africa IMP4279 Sales Quantity by Country (2021-2032)
  • 11.3.2 Middle East & Africa IMP4279 Consumption Value by Country (2021-2032)
  • 11.3.3 Turkey Market Size and Forecast (2021-2032)
  • 11.3.4 Egypt Market Size and Forecast (2021-2032)
  • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
  • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

• 12.1 IMP4279 Market Drivers
• 12.2 IMP4279 Market Restraints
• 12.3 IMP4279 Trends Analysis
• 12.4 Porters Five Forces Analysis
  • 12.4.1 Threat of New Entrants
  • 12.4.2 Bargaining Power of Suppliers
  • 12.4.3 Bargaining Power of Buyers
  • 12.4.4 Threat of Substitutes
  • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

• 13.1 Raw Material of IMP4279 and Key Manufacturers
• 13.2 Manufacturing Costs Percentage of IMP4279
• 13.3 IMP4279 Production Process
• 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

• 14.1 Sales Channel
  • 14.1.1 Direct to End-User
  • 14.1.2 Distributors
• 14.2 IMP4279 Typical Distributors
• 14.3 IMP4279 Typical Customers

15 Research Findings and Conclusion

16 Appendix

• 16.1 Methodology
• 16.2 Research Process and Data Source

According to our (Global Info Research) latest study, the global IMP4279 market size was valued at US$ 3.09 million in 2025 and is forecast to a readjusted size of US$ 50.90 million by 2032 with a CAGR of 8.7% during review period.
IMP4279 is a novel DNA damage response pathway inhibitor independently developed by Impact Therapeutics at the preclinical research stage, focusing on exploring unmet clinical needs in the field of oncology. Designed and optimized based on the company’s technological expertise in DDR inhibitor platforms, this compound exhibits high target selectivity and favorable druggability. It aims to inhibit tumor cell proliferation and enhance the sensitivity of other antineoplastic therapies by interfering with the DNA repair mechanism of tumor cells. As an investigational innovative small-molecule drug, IMP4279 has not yet entered clinical trials, and its mechanism of action, safety profile, and efficacy are still being continuously verified in preclinical models. In the future, it is expected to be used as a single agent or in combination with chemotherapy, targeted therapy, and immunotherapy for the treatment of various solid tumors, providing new potential therapeutic options for patients with malignant tumors.In 2025, global IMP4279 production reached approximately 2,000 vials.
As a novel preclinical DDR pathway inhibitor, IMP4279 operates within a rapidly expanding global oncology market driven by unmet medical needs and the growing adoption of targeted therapies. The broader DNA damage repair (DDR) inhibitor sector, underpinned by the synthetic lethality mechanism, has gained significant traction, establishing itself as a high-growth and strategically vital segment within precision oncology. This market landscape is characterized by a robust pipeline of innovative agents, a shift towards novel targets beyond established PARP inhibitors, and an increasing emphasis on combination regimens to overcome treatment resistance and enhance efficacy. Positioned at the forefront of this trend, IMP4279 benefits from the favorable industry dynamics and the proven commercial success of earlier DDR drugs. Its clinical-stage potential is underscored by the strong market demand for next-generation treatments that offer improved selectivity, safety profiles, and the ability to synergize with existing chemo-, targeted, and immunotherapies. Despite being in the preclinical phase, IMP4279 holds considerable market promise, targeting a broad spectrum of solid tumors where current standards of care are limited. Its development aligns with the global pharmaceutical industry's strategic focus on first-in-class and best-in-class molecules, which command premium pricing and significant market penetration upon successful launch.While competitive pressures are intensifying as more players enter the DDR space, IMP4279's distinct mechanism of action and early-stage positioning provide a valuable opportunity to capture future market share. Successful clinical advancement would allow IMP4279 to address the persistent gaps in cancer care, solidifying its role as a key component in the next wave of transformative oncological therapies and securing a strong commercial foothold in the expanding global DDR inhibitor market.
This report is a detailed and comprehensive analysis for global IMP4279 market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global IMP4279 market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global IMP4279 market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global IMP4279 market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
Global IMP4279 market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for IMP4279
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global IMP4279 market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Nanjing IMPACT Therapeutics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
IMP4279 market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
10mg
50mg
Market segment by Dosage Form
Freeze-Dried Powder for Injection
Capsule
Market segment by Route of Administration
Oral Administration
Intravenous Injection
Market segment by Sales Channels
Hospital
Retail
Online
Market segment by Application
Peripheral T-Cell Lymphoma (PTCL)
Relapsed Or Refractory Peripheral T-Cell Lymphoma (R/R PTCL)
T-Cell Hematologic Malignancies
Others
Major players covered
Nanjing IMPACT Therapeutics
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe IMP4279 product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of IMP4279, with price, sales quantity, revenue, and global market share of IMP4279 from 2021 to 2026.
Chapter 3, the IMP4279 competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the IMP4279 breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and IMP4279 market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of IMP4279.
Chapter 14 and 15, to describe IMP4279 sales channel, distributors, customers, research findings and conclusion.